Ban Randy 4
4 · Inspire Medical Systems, Inc. · Filed Aug 19, 2024
Insider Transaction Report
Form 4
Ban Randy
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-08-15$42.15/sh+16,139$680,259→ 19,195 total - Sale
Common Stock
2024-08-15$189.06/sh−776$146,711→ 18,419 total - Sale
Common Stock
2024-08-15$191.92/sh−2,072$397,658→ 14,688 total - Sale
Common Stock
2024-08-15$192.60/sh−1,150$221,490→ 13,538 total - Sale
Common Stock
2024-08-15$194.91/sh−2,350$458,039→ 3,056 total - Sale
Common Stock
2024-08-16$187.10/sh−900$168,390→ 7,017 total - Sale
Common Stock
2024-08-16$188.66/sh−3,066$578,432→ 3,951 total - Sale
Common Stock
2024-08-16$189.64/sh−895$169,728→ 3,056 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-15−16,139→ 4,861 totalExercise: $42.15Exp: 2028-12-18→ Common Stock (16,139 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-16−4,861→ 0 totalExercise: $42.15Exp: 2028-12-18→ Common Stock (4,861 underlying) - Sale
Common Stock
2024-08-15$190.20/sh−1,659$315,542→ 16,760 total - Sale
Common Stock
2024-08-15$193.92/sh−8,132$1,576,957→ 5,406 total - Exercise/Conversion
Common Stock
2024-08-16$42.15/sh+4,861$204,891→ 7,917 total
Holdings
- 167(indirect: By son)
Common Stock
- 166(indirect: By daughter)
Common Stock
Footnotes (11)
- [F1]Includes 27 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated February 27, 2024.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.26 to $189.855. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F11]The option is fully vested and exercisable.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.995 to $189.285. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.08 to $190.845. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.225 to $192.18. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.26 to $193.22. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.4 to $194.32. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.81 to $195.15. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.90 to $187.71. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.255 to $189.24. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote .